NeuroMetrix gets clearance to market an over-the-counter pain management device

Photo taken from the company’s website.

A woman gardens while wearing a NeuroMetrix pain-management device on her leg.

Waltham medical device maker NeuroMetrix Inc. said Tuesday that its wearable technology for treatment of chronic pain has received a clearance from the Food and Drug Administration for over-the-counter use.

The device is based on wearable technology that utilizes comfortable, non-invasive electrical stimulation of sensory nerves to induce safe and effective pain relief, the company said in a press release. The technology is presently deployed in the company’s Sensus Pain Management System.

In a statement, NeuroMetrix president and chief executive Shai N. Gozani said: “Patient response to Sensus, our prescription wearable device for treatment of chronic pain, has been very positive since it was launched in early 2013. We believe that there is a substantial consumer market for an over-the-counter version of this technology. The ability to offer both prescription and over-the-counter products will give us maximal market exposure and allow us to reach more people with chronic pain. We anticipate a commercial launch in 2015.”

Chris Reidy can be reached at
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of